Abstract
The process and kinetics involved in drug distribution and disposition are complex, and drug events often happen simultaneously. The process is governed by a variety of factors that must be properly defined and quantified for designing optimum drug therapy regimens through pharmacokinetic models. A pharmacokinetic model is a hypothesis using mathematical terms to describe quantitative relationships and is efficient in describing the time course of the drug throughout the body and is helpful in computing and calculating desired pharmacokinetic parameters which are needed for achieving the overall objective of drug therapy. The predictive capability of a model lies in the proper selection and development of mathematical function(s) that parameterize the essential factors governing the kinetic process. Such mathematical models can be devised to simulate the rate processes of drug absorption, distribution and elimination to describe and predict drug concentrations in the body as a function of time. The field is under constant upgradation to match with recent and novel drug delivery systems and therapeutic approaches for achieving the overall objective of the therapeutic regimen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aarons L (2005) Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed. Br J Clin Pharmacol 60:581–583
Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–515
Brahmankar DM, Jaiswal SB (2015) Biopharmaceutics and pharmacokinetics - a treatise. Vallabh Prakashan, India
Brochot C, Tóth J, Bois FY (2005) Lumping in pharmacokinetics. J Pharmacokinet Pharmacodyn 32:719–736
Chapman KR, Fogarty CM, Peckitt C et al (2011) Delivery characteristics and patients’ handling of two single-dose dry-powder inhalers used in COPD. Int J Chron Obstruct Pulmon Dis 6:353–363
Di Muria M, Lamberti G, Titomanlio G (2010) Physiologically based pharmacokinetics: a simple, all-purpose model. Ind Eng Chem Res 49:2969–2978
Dogra P, Butner JD, Ruiz RamÃrez J et al (2020) A mathematical model to predict nanomedicine pharmacokinetics and tumour delivery. Comput Struct Biotechnol J 18:518–531
Dolovich MB, Kuttler A, Dimke TJ et al (2019) Biophysical model to predict lung delivery from a dual bronchodilator dry-powder inhaler. Int J Pharm X 1:100018. https://doi.org/10.1016/j.ijpx.2019.100018
Gallo JM, Vicini P, Orlansky A et al (2004) Pharmacokinetic model-predicted anticancer drug concentrations in human tumors. Clin Cancer Res 10:8048–8058
Gerlowski LE, Jain RK (1983) Physiologically based pharmacokinetic modelling: principles and applications. J Pharm Sci 72:1103–1127
Grgic B, Finlay WH, Heenan AF (2004) Regional aerosol deposition and flow measurements in an idealized mouth and throat. J Aerosol Sci 35:21–32
Groo AC, Bossiere M, Trichard L et al (2015) In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor. Nanomedicine (Lond) 10:589–601
Jones HM, Rowland-Yeo K (2013) Basic concepts in physiologically based pharmacokinetic modelling in drug discovery and development. CPT Pharmacometrics Syst Pharmacol 2:1–12
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 3:703–717
Nestorov IA, Aarons LJ, Arundel PA (1998) Lumping of whole-body physiologically based pharmacokinetic models. J Pharmacokinet Biopharm 26:21–46
Notari RE (2013) Biopharmaceutics and clinical pharmacokinetics- an introduction, 4th edn. New York, NY, Marcel Dekker
Roberts MS, Magnusson BM, Burczynski FJ et al (2002) Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 41:751–790
Shargel L, Wu-Pong S, Yu ABC (2016) Applied biopharmaceutics & pharmacokinetics, 6e. Mc GrawHill, New York
Shiffman ML, Sugerman HJ, Moore EW (1990) Human gallbladder mucosal function. Effect of concentration and acidification of bile on cholesterol and calcium solubility. Gastroenterology 99:1452–1459
Winter ME (2004) Basic clinical pharmacokinetics, 4th edn. Lippincott Williams & Wilkins, Philadelphia, PA
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Shankar, R., Pathak, K. (2023). An Update on Pharmacokinetic Models. In: Singh, P.P. (eds) Recent Advances in Pharmaceutical Innovation and Research. Springer, Singapore. https://doi.org/10.1007/978-981-99-2302-1_16
Download citation
DOI: https://doi.org/10.1007/978-981-99-2302-1_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-2301-4
Online ISBN: 978-981-99-2302-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)